Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Cherry Biotech develops advanced organ-on-chip and 3D cell culture technologies that replicate human physiology in vitro. Their CubiX platform enables creation of immunocompetent, vascularized tissue models such as liver, skin, lung, adipose tissue, and tumor microenvironments. These systems are used by pharma/biotech clients to improve preclinical drug testing accuracy while reducing reliance on animal studies. The company has received multiple European innovation awards and patents for its technologies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Cherry Biotech.